Firefly Neuroscience Executive Chair Dave Johnson joined Steve Darling from to announce the company's strategic partnership with the Neurology Consultants of Dallas (NCD). This collaboration aims to enhance early detection efforts and improve disease management for patients experiencing cognitive decline. Johnson explained that NCD will integrate Firefly's Brain Network Analytics (BNA) technology into their patient workflow. This partnership also includes conducting clinical studies to identify biomarkers that could predict the onset of dementia, potentially optimizing patient care pathways. Furthermore, Johnson emphasized the significance of establishing a cognitive baseline for every patient. By doing so, healthcare providers can more accurately monitor cognitive changes over time, facilitating the early detection and effective management of cognitive decline. The incorporation of BNA technology is anticipated to revolutionize neurology testing across the United States, promoting the widespread adoption of advanced diagnostic tools and benefiting millions of patients. #proactiveinvestors #fireflyneiroscienceinc #nasdaq #aiff #brainhealth #neurologyconsultantsofdallas #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews